212 related articles for article (PubMed ID: 21898481)
1. Shedding of syndecan-1 from human hepatocytes alters very low density lipoprotein clearance.
Deng Y; Foley EM; Gonzales JC; Gordts PL; Li Y; Esko JD
Hepatology; 2012 Jan; 55(1):277-86. PubMed ID: 21898481
[TBL] [Abstract][Full Text] [Related]
2. Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice.
Stanford KI; Bishop JR; Foley EM; Gonzales JC; Niesman IR; Witztum JL; Esko JD
J Clin Invest; 2009 Nov; 119(11):3236-45. PubMed ID: 19805913
[TBL] [Abstract][Full Text] [Related]
3. Heparan sulfate 2-O-sulfotransferase is required for triglyceride-rich lipoprotein clearance.
Stanford KI; Wang L; Castagnola J; Song D; Bishop JR; Brown JR; Lawrence R; Bai X; Habuchi H; Tanaka M; Cardoso WV; Kimata K; Esko JD
J Biol Chem; 2010 Jan; 285(1):286-94. PubMed ID: 19889634
[TBL] [Abstract][Full Text] [Related]
4. Triglyceride-rich lipoprotein binding and uptake by heparan sulfate proteoglycan receptors in a CRISPR/Cas9 library of Hep3B mutants.
Anower-E-Khuda F; Singh G; Deng Y; Gordts PLSM; Esko JD
Glycobiology; 2019 Jul; 29(8):582-592. PubMed ID: 31094413
[TBL] [Abstract][Full Text] [Related]
5. Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase.
Fitzgerald ML; Wang Z; Park PW; Murphy G; Bernfield M
J Cell Biol; 2000 Feb; 148(4):811-24. PubMed ID: 10684261
[TBL] [Abstract][Full Text] [Related]
6. Hepatic heparan sulfate proteoglycans and endocytic clearance of triglyceride-rich lipoproteins.
Foley EM; Esko JD
Prog Mol Biol Transl Sci; 2010; 93():213-33. PubMed ID: 20807647
[TBL] [Abstract][Full Text] [Related]
7. Insulin-dependent diabetes mellitus in mice does not alter liver heparan sulfate.
Bishop JR; Foley E; Lawrence R; Esko JD
J Biol Chem; 2010 May; 285(19):14658-62. PubMed ID: 20236939
[TBL] [Abstract][Full Text] [Related]
8. Heparan sulfate chains of syndecan-1 regulate ectodomain shedding.
Ramani VC; Pruett PS; Thompson CA; DeLucas LD; Sanderson RD
J Biol Chem; 2012 Mar; 287(13):9952-9961. PubMed ID: 22298773
[TBL] [Abstract][Full Text] [Related]
9. Porphyromonas gingivalis lipopolysaccharide induces shedding of syndecan-1 expressed by gingival epithelial cells.
Andrian E; Grenier D; Rouabhia M
J Cell Physiol; 2005 Jul; 204(1):178-83. PubMed ID: 15648090
[TBL] [Abstract][Full Text] [Related]
10. The adaptor protein PID1 regulates receptor-dependent endocytosis of postprandial triglyceride-rich lipoproteins.
Fischer AW; Albers K; Krott LM; Hoffzimmer B; Heine M; Schmale H; Scheja L; Gordts PLSM; Heeren J
Mol Metab; 2018 Oct; 16():88-99. PubMed ID: 30100244
[TBL] [Abstract][Full Text] [Related]
11. Hepatic syndecan-1 changes associate with dyslipidemia after renal transplantation.
Adepu S; Katta K; Tietge UJ; Kwakernaak AJ; Dam W; van Goor H; Dullaart RP; Navis GJ; Bakker SJ; van den Born J
Am J Transplant; 2014 Oct; 14(10):2328-38. PubMed ID: 25154787
[TBL] [Abstract][Full Text] [Related]
12. Syndecan-1 inhibits early stages of liver fibrogenesis by interfering with TGFβ1 action and upregulating MMP14.
Regős E; Abdelfattah HH; Reszegi A; Szilák L; Werling K; Szabó G; Kiss A; Schaff Z; Kovalszky I; Baghy K
Matrix Biol; 2018 Aug; 68-69():474-489. PubMed ID: 29454902
[TBL] [Abstract][Full Text] [Related]
13. Shedding of syndecan-4 promotes immune cell recruitment and mitigates cardiac dysfunction after lipopolysaccharide challenge in mice.
Strand ME; Aronsen JM; Braathen B; Sjaastad I; Kvaløy H; Tønnessen T; Christensen G; Lunde IG
J Mol Cell Cardiol; 2015 Nov; 88():133-44. PubMed ID: 26449522
[TBL] [Abstract][Full Text] [Related]
14. Syndecan-1 Promotes Hepatocyte-Like Differentiation of Hepatoma Cells Targeting Ets-1 and AP-1.
Hollósi P; Váncza L; Karászi K; Dobos K; Péterfia B; Tátrai E; Tátrai P; Szarvas T; Paku S; Szilák L; Kovalszky I
Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32977498
[TBL] [Abstract][Full Text] [Related]
15. Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation.
Subramanian SV; Fitzgerald ML; Bernfield M
J Biol Chem; 1997 Jun; 272(23):14713-20. PubMed ID: 9169435
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte-specific IKK-β activation enhances VLDL-triglyceride production in APOE*3-Leiden mice.
van Diepen JA; Wong MC; Guigas B; Bos J; Stienstra R; Hodson L; Shoelson SE; Berbée JF; Rensen PC; Romijn JA; Havekes LM; Voshol PJ
J Lipid Res; 2011 May; 52(5):942-50. PubMed ID: 21357939
[TBL] [Abstract][Full Text] [Related]
17. Targeted deletion of hepatocyte ABCA1 leads to very low density lipoprotein triglyceride overproduction and low density lipoprotein hypercatabolism.
Chung S; Timmins JM; Duong M; Degirolamo C; Rong S; Sawyer JK; Singaraja RR; Hayden MR; Maeda N; Rudel LL; Shelness GS; Parks JS
J Biol Chem; 2010 Apr; 285(16):12197-209. PubMed ID: 20178985
[TBL] [Abstract][Full Text] [Related]
18. Heparanase-1-induced shedding of heparan sulfate from syndecan-1 in hepatocarcinoma cell facilitates lymphatic endothelial cell proliferation via VEGF-C/ERK pathway.
Yu S; Lv H; Zhang H; Jiang Y; Hong Y; Xia R; Zhang Q; Ju W; Jiang L; Ou G; Zhang J; Wang S; Zhang J
Biochem Biophys Res Commun; 2017 Apr; 485(2):432-439. PubMed ID: 28209511
[TBL] [Abstract][Full Text] [Related]
19. Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans.
Gonzales JC; Gordts PL; Foley EM; Esko JD
J Clin Invest; 2013 Jun; 123(6):2742-51. PubMed ID: 23676495
[TBL] [Abstract][Full Text] [Related]
20. A disintegrin and metalloproteinase 17 (ADAM17) mediates inflammation-induced shedding of syndecan-1 and -4 by lung epithelial cells.
Pruessmeyer J; Martin C; Hess FM; Schwarz N; Schmidt S; Kogel T; Hoettecke N; Schmidt B; Sechi A; Uhlig S; Ludwig A
J Biol Chem; 2010 Jan; 285(1):555-64. PubMed ID: 19875451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
